Ind-Swift Laboratories Limited (NSE:INDSWFTLAB)
India flag India · Delayed Price · Currency is INR
109.63
+2.78 (2.60%)
Jan 23, 2026, 3:30 PM IST

Ind-Swift Laboratories Company Description

Ind-Swift Laboratories Limited, together with its subsidiaries, develops, manufactures, and sells active pharmaceutical ingredients (APIs), intermediates, and formulations in India and internationally.

The company offers APIs in various therapeutic areas, including macrolide antibiotic, cardiovascular, antihistaminic, antidiabetic, antipsychotic, bone resorption inhibitor, Parkinson’s disease, hyperparathyrodism, analgesic, aromatase inhibitor, nootropic, antidiarrhoeal/antiprotozoal, alcohol abstinence, antineoplastic, ADHD symptoms, anticancer, hypercholesterolemia, antimuscarinic, antimigraine, and thrombocytopenia.

It also provides reference standards and impurities for acamprosate calcium, anastrozole, aripiprazole, atorvastatin calcium, azithromycin dihydrate, bexarotene, cinacalcet hydrochloride, clopidogrel bisulphate, clopidogrel hydrochloride, dapoxetine hydrochloride, donepezil hydrochloride, ezetimibe, fexofenadine hydrochloride, imatinib mesylate, ivabradine hydrochloride, ivabradine oxalate, letrozole, mecloxamine citrate, naratriptan hydrochloride, nateglinide, nitazoxanide, nitrosamine, pazopanib hydrochloride, quetiapine hemifumarate, raltegravir potassium, ropinirole hydrochloride, rosuvastatin calcium, saxagliptin monohydrate, silodosin, and temozolomide, as well as contract research and manufacturing services.

The company exports its products. Ind-Swift Laboratories Limited was incorporated in 1995 and is based in Manimajra, India.

Ind-Swift Laboratories Limited
Ind-Swift Laboratories logo
CountryIndia
Founded1995
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees1,246

Contact Details

Address:
Shivalik Enclave
Manimajra, Chandigarh 160101
India
Phone91 17 2506 1850
Websiteindswiftlabs.com

Stock Details

Ticker SymbolINDSWFTLAB
ExchangeNational Stock Exchange of India
Fiscal YearApril - March
Reporting CurrencyINR
ISIN NumberINE915B01019
SIC Code2833

Key Executives

NamePosition
Navrattan R. MunjalChairman and MD
Himanshu Jain BComJoint MD and Whole Time Director
Gagan AggarwalChief Financial Officer
Lalit GoyalVice President of Accounts
Pardeep VermaVice President of Corporate Affairs, Compliance Officer and Company Secretary
Rishav MehtaExecutive Director
Sahil MunjalExecutive Director
Anil Ratanlal AgrawalChief Operating Officer
Varun ChhabraSenior Vice President of Marketing
Akashdeep SharmaVice President of Human Resources